D.E. Shaw & Co Portfolio holdings
D. E. Shaw & Co., L.P., founded in 1988 by David E. Shaw, a former Columbia University computer science professor, is a New York City-based global investment management firm renowned for pioneering quantitative investing, managing over $70 billion in assets as of late 2024. Starting with $28 million from Paloma Partners and private investors, the firm employs sophisticated mathematical models and proprietary algorithms—initially developed by a team of scientists and programmers—to exploit market anomalies across public and private markets, including equities, fixed income, and alternatives. Headquartered above a Greenwich Village bookstore in its early days, it now boasts over 2,500 employees across offices in North America, Europe, and Asia, led by a seven-member Executive Committee since Shaw stepped back in 2001 to focus on D. E. Shaw Research. Despite setbacks like the 1998 Russia debt crisis and the 2008 financial downturn, the firm has maintained a reputation for analytical rigor, risk management, and innovation, balancing its computational roots with discretionary strategies.
Top Buys
| 1 |
NVIDIA
NVDA
|
+$728M |
| 2 |
Vanguard Intermediate-Term Corporate Bond ETF
VCIT
|
+$625M |
| 3 |
Merck
MRK
|
+$498M |
| 4 |
Bank of America
BAC
|
+$487M |
| 5 |
Fortinet
FTNT
|
+$321M |
Top Sells
| 1 |
Tesla
TSLA
|
+$696M |
| 2 |
Adobe
ADBE
|
+$610M |
| 3 |
Accenture
ACN
|
+$518M |
| 4 |
Microsoft
MSFT
|
+$495M |
| 5 |
Broadcom
AVGO
|
+$471M |
Sector Composition
| 1 | Technology | 22.95% |
| 2 | Consumer Discretionary | 14.11% |
| 3 | Healthcare | 10.4% |
| 4 | Financials | 9.83% |
| 5 | Industrials | 7.59% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
2226
Wipro
WIT
$29.2B
| $644K | ﹤0.01% |
+198,738
| New | +$644K |
|
2227
Schwab US Large-Cap Growth ETF
SCHG
$49.3B
| $640K | ﹤0.01% |
+24,576
| New | +$640K |
|
2228
Cabot Corp
CBT
$4.33B
| $639K | ﹤0.01% |
5,713
-18,238
| -76% | -$2.04M |
|
2229
Rimini Street
RMNI
$429M
| $637K | ﹤0.01% |
344,247
-179,982
| -34% | -$333K |
|
2230
Dimensional US Small Cap ETF
DFAS
$11.4B
| $636K | ﹤0.01% |
9,810
-28,657
| -74% | -$1.86M |
|
2231
Iovance Biotherapeutics
IOVA
$876M
| $636K | ﹤0.01% |
67,748
-588,082
| -90% | -$5.52M |
|
2232
Blackbaud
BLKB
$3.4B
| $631K | ﹤0.01% |
7,448
+1,380
| +23% | +$117K |
|
2233
Editas Medicine
EDIT
$244M
| $630K | ﹤0.01% |
184,715
-366,138
| -66% | -$1.25M |
|
2234
Inspire Medical Systems
INSP
$2.45B
| $627K | ﹤0.01% |
2,973
-20,310
| -87% | -$4.29M |
|
2235
Invesco S&P SmallCap 600 Revenue ETF
RWJ
$1.63B
| $626K | ﹤0.01% |
13,701
+1,046
| +8% | +$47.8K |
|
2236
Traeger
COOK
$188M
| $626K | ﹤0.01% |
170,129
+46,410
| +38% | +$171K |
|
2237
Independent Bank Corp
IBCP
$666M
| $624K | ﹤0.01% |
18,700
-3,849
| -17% | -$128K |
|
2238
iShares MSCI Turkey ETF
TUR
$160M
| $623K | ﹤0.01% |
17,138
-34,725
| -67% | -$1.26M |
|
2239
Cytokinetics
CYTK
$6.38B
| $623K | ﹤0.01% |
+11,790
| New | +$623K |
|
2240
CNO Financial Group
CNO
$3.83B
| $622K | ﹤0.01% |
17,729
-110,964
| -86% | -$3.89M |
|
2241
Aspen Aerogels
ASPN
$560M
| $622K | ﹤0.01% |
22,465
-519,040
| -96% | -$14.4M |
|
2242
TELUS International
TIXT
$1.25B
| $620K | ﹤0.01% |
+158,883
| New | +$620K |
|
2243
Old Republic International
ORI
$10.1B
| $620K | ﹤0.01% |
17,491
-29,078
| -62% | -$1.03M |
|
2244
National Research Corp
NRC
$374M
| $619K | ﹤0.01% |
27,083
-9,282
| -26% | -$212K |
|
2245
Sasol
SSL
$4.53B
| $614K | ﹤0.01% |
90,770
-167,053
| -65% | -$1.13M |
|
2246
iShares S&P Small-Cap 600 Value ETF
IJS
$6.72B
| $613K | ﹤0.01% |
5,691
-66,847
| -92% | -$7.2M |
|
2247
Invesco S&P MidCap 400 Pure Value ETF
RFV
$279M
| $608K | ﹤0.01% |
5,133
| – | – |
|
2248
Madison Square Garden
MSGE
$2.06B
| $602K | ﹤0.01% |
+14,166
| New | +$602K |
|
2249
Vanguard Extended Market ETF
VXF
$24.5B
| $601K | ﹤0.01% |
3,303
-38,472
| -92% | -$7M |
|
2250
EastGroup Properties
EGP
$8.94B
| $600K | ﹤0.01% |
+3,213
| New | +$600K |
|